Demonstration by synovial fluid analysis of the efficacy in horses of an investigational drug (L-1016)

Research output: Contribution to journalArticle

Abstract

A glycosaminoglycan polysulfate ester, L-1016, was administered intra-articularly over a period of six-weeks to selected horses with joint disorders which demonstrated by synovial fluid analysis lesions and/or degeneration of the articular cartilage and impairment of synovial membrane function. Over the course of treatment, significant changes in synovial fluid viscosity and protein were observed. In general, these laboratory data were reflected directly in clinical observations. Response to the treatment was characterized by decreases in outward signs of swelling, increases in flexion and lessening of lameness.

Original languageEnglish (US)
Pages (from-to)42-50
Number of pages9
JournalJournal of Equine Veterinary Science
Volume2
Issue number2
DOIs
StatePublished - Jan 1 1982

ASJC Scopus subject areas

  • Equine

Fingerprint Dive into the research topics of 'Demonstration by synovial fluid analysis of the efficacy in horses of an investigational drug (L-1016)'. Together they form a unique fingerprint.

  • Cite this